ebook Munafa Stock Market Course + Intraday & FNO calls  

       

PRVB announcements Provention Bio, Inc. announcements and dividends declared NASDAQ

Provention Bio, Inc. Complete list of announcements declared & dividend announcements by Provention Bio, Inc. PRVB

Provention Bio, Inc. PRVB listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Provention Bio, Inc. PRVB

: Sanofi to buy Provention Bio in deal worth .9 billion
Shares of Provention Bio Inc. PRVB skyrocketed 260% in premarket trading Monday, after French pharmaceutical group Sanofi SNYFR:SAN said Monday that it will buy the U.S.-based biopharmaceutical company focused on autoimmune diseases, for per share in c
Announcement as on 13 March 2023

Sanofi to buy Provention Bio for per share in deal worth .9 billion
Sanofi to buy Provention Bio for per share in deal worth .9 billion
Announcement as on 13 March 2023

Provention Bio gets FDA approval for treatment that can delay onset of Type 1 diabetes
Shares of Provention Bio Inc. were down 3.9% in trading on Friday morning, the day after the Food and Drug Administration approved the company's treatment that can delay the onset of Type 1 diabetes in some patients. The intravenous therapy, Tzield, can d
Announcement as on 18 November 2022

Provention Bio Resubmits BLA For Teplizumab For Delay Of Clinical Type 1 Diabetes - Quick Facts
(RTTNews) - Biopharmaceutical company Provention Bio, Inc. (PRVB) announced Tuesday it has resubmitted the Biologics License Application (BLA) for teplizumab for the delay of clinical type 1 diabetes (T1D) in at-risk individuals.
Announcement as on 22 February 2022

Announcements by Provention Bio, Inc. first page |

PRVB Provention Bio, Inc. current price & indicator signals

Moving Averages for Provention Bio, Inc.

  • 5Day Average: 24.43
  • 12Day Average: 24.38
  • 20Day Average: 24.34
  • 50Day Average: 18.5
  • 100Day Average: 13.95
  • 150Day Average: 11.73
  • 200Day Average: 9.96

PRVB Indicators & signals

Indicator MACD (12,26,9)

24.33, 22.96, 1.79
Indicator MACD is in positive zone

Indicator ADX (14)

50, 56.76, 18.92
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 70
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of PRVB Provention Bio, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
26 Wed Apr 2023 24.98 24.98 to 25.00 3.1% 4.92 times
25 Tue Apr 2023 24.23 24.20 to 24.39 -0.7% 1.02 times
24 Mon Apr 2023 24.40 24.27 to 24.41 0.33% 0.86 times
21 Fri Apr 2023 24.32 24.22 to 24.33 0.33% 1.59 times
20 Thu Apr 2023 24.24 24.21 to 24.48 -0.82% 1.24 times
19 Wed Apr 2023 24.44 24.38 to 24.49 -0.04% 0.86 times
18 Tue Apr 2023 24.45 24.33 to 24.46 0.41% 0.76 times
17 Mon Apr 2023 24.35 24.34 to 24.42 0% 1.15 times
14 Fri Apr 2023 24.35 24.25 to 24.43 0.12% 1.07 times
13 Thu Apr 2023 24.32 24.26 to 24.37 0.21% 0.67 times
12 Wed Apr 2023 24.27 24.17 to 24.34 0.04% 0.78 times
11 Tue Apr 2023 24.26 24.16 to 24.43 -0.74% 1.36 times

Videos related to: PRVB announcements Provention Bio, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

PRVB announcements Provention Bio, Inc. announcements and dividends declared NASDAQ

 

Back to top